Naveed Sattar Selected Research

Coronary Disease (Coronary Heart Disease)

1/2021	Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses.
1/2021	Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study.
1/2021	Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity - a cross-sectional study.
12/2020	Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective studies with 1,164,029 participants.
11/2020	Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data.
10/2020	Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.
10/2019	Morning plasma cortisol as a cardiovascular risk factor: findings from prospective cohort and Mendelian randomization studies.
1/2019	Subsequent Event Risk in Individuals With Established Coronary Heart Disease.
1/2019	Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.
1/2018	Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naveed Sattar Research Topics

Disease

127	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2002
124	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 10/2004
68	Heart Failure 04/2022 - 04/2007
65	Inflammation (Inflammations) 01/2022 - 06/2004
65	Coronary Disease (Coronary Heart Disease) 01/2021 - 07/2002
50	Insulin Resistance 01/2022 - 11/2002
47	Stroke (Strokes) 01/2022 - 01/2003
45	Myocardial Infarction 01/2022 - 07/2006
40	Obesity 01/2022 - 11/2003
29	Vascular Diseases (Vascular Disease) 12/2021 - 05/2004
27	Hypertension (High Blood Pressure) 01/2022 - 09/2002
25	Rheumatoid Arthritis 01/2022 - 06/2004
21	Weight Loss (Weight Reduction) 01/2022 - 02/2002
21	Diabetes Mellitus 01/2021 - 02/2009
19	Body Weight (Weight, Body) 01/2022 - 08/2005
17	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 04/2007
16	Atherosclerosis 10/2021 - 11/2003
15	Birth Weight (Birth Weights) 01/2017 - 03/2004
14	COVID-19 10/2022 - 01/2020
14	Neoplasms (Cancer) 01/2022 - 01/2002
14	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 09/2002
14	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2021 - 11/2007
12	Infections 10/2021 - 10/2008
11	ST Elevation Myocardial Infarction 01/2021 - 01/2016
11	Cognitive Dysfunction 01/2020 - 01/2010
10	Non-alcoholic Fatty Liver Disease 01/2022 - 07/2006
10	Pre-Eclampsia (Preeclampsia) 07/2018 - 02/2003
9	Albuminuria 08/2021 - 04/2017
9	Thrombosis (Thrombus) 01/2021 - 11/2003
8	Chronic Renal Insufficiency 01/2021 - 05/2013
8	Ischemic Stroke 12/2020 - 12/2008
8	Infarction (Infarctions) 01/2019 - 06/2007
8	Gestational Diabetes (Gestational Diabetes Mellitus) 07/2018 - 05/2011
8	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2012 - 07/2002
6	Peripheral Arterial Disease 02/2022 - 01/2019
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 03/2007
6	Atrial Fibrillation 09/2021 - 01/2003
6	Prediabetic State (Prediabetes) 01/2021 - 10/2008
6	Atherosclerotic Plaque (Atheroma) 11/2020 - 02/2008
6	Necrosis 10/2016 - 04/2007
6	Arthritis (Polyarthritis) 04/2014 - 02/2003

Drug/Important Bio-Agent (IBA)

78	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 09/2002
75	LipidsIBA 01/2022 - 01/2003
54	Insulin (Novolin)FDA Link 01/2022 - 07/2002
54	C-Reactive ProteinIBA 01/2022 - 01/2002
49	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
44	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 02/2002
38	Triglycerides (Triacylglycerol)IBA 01/2022 - 09/2002
36	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 04/2007
32	HDL CholesterolIBA 01/2022 - 11/2002
30	CholesterolIBA 01/2022 - 01/2003
30	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 12/2009
30	LeptinIBA 01/2019 - 01/2002
28	AdiponectinIBA 07/2018 - 11/2003
25	LDL CholesterolIBA 02/2022 - 11/2003
24	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 02/2002
22	Lipoproteins (Lipoprotein)IBA 12/2021 - 01/2003
22	Interleukin-6 (Interleukin 6)IBA 07/2018 - 01/2002
21	empagliflozinIBA 01/2022 - 01/2016
21	Pravastatin (Pravachol)FDA LinkGeneric 01/2020 - 02/2007
17	Pharmaceutical PreparationsIBA 01/2022 - 10/2011
16	ApolipoproteinsIBA 10/2020 - 11/2003
14	CreatinineIBA 01/2022 - 08/2013
14	omega-Chloroacetophenone (Mace)IBA 01/2022 - 02/2015
13	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2022 - 05/2017
13	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2012
13	AdipokinesIBA 01/2017 - 05/2007
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2003
12	Troponin T (Troponin T1)IBA 01/2022 - 01/2014
12	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 07/2002
11	SodiumIBA 04/2022 - 10/2010
10	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 11/2017
10	Vitamin D FDA LinkGeneric 03/2021 - 07/2011
10	oxidized low density lipoproteinIBA 11/2018 - 02/2008
9	Sodium-Glucose Transport ProteinsIBA 01/2022 - 05/2017
9	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 09/2002
9	Hormones (Hormone)IBA 12/2020 - 08/2005
9	Fatty Acids (Saturated Fatty Acids)IBA 12/2020 - 05/2004
8	AlbuminsIBA 01/2022 - 01/2004
8	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 10/2019
8	Biological ProductsIBA 12/2021 - 04/2008
8	Apolipoproteins E (ApoE)IBA 10/2020 - 02/2008
8	Fibrinogen (Factor I)FDA Link 01/2019 - 07/2002
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 11/2004
7	25-hydroxyvitamin DIBA 02/2021 - 05/2011
7	HDL LipoproteinsIBA 12/2020 - 09/2002
7	tocilizumab (atlizumab)FDA Link 01/2020 - 03/2012
7	Alanine Transaminase (SGPT)IBA 01/2019 - 11/2004
7	CytokinesIBA 11/2017 - 04/2007
7	von Willebrand FactorIBA 09/2015 - 07/2002
6	TroponinIBA 01/2022 - 08/2017
6	Gliclazide (Diamicron)IBA 01/2020 - 01/2014
6	perindopril drug combination indapamideIBA 01/2020 - 01/2014
6	TransferasesIBA 03/2016 - 05/2008
6	InterleukinsIBA 01/2013 - 05/2007

Therapy/Procedure

74	Therapeutics 01/2022 - 02/2002
8	Glycemic Control 01/2022 - 02/2014
7	Surgical Amputation (Amputations) 01/2022 - 01/2016
7	Bariatric Surgery 11/2021 - 06/2010
7	Percutaneous Coronary Intervention 01/2020 - 02/2016